Overview
What is Alzheimer's Drug Discovery Foundation?
The Alzheimer's Drug Discovery Foundation is a New York-based nonprofit organization, located at 57 West 57th Street, dedicated to expediting the discovery of drugs to prevent, treat, and ultimately cure Alzheimer's disease and related dementias. With a mission to accelerate research in academia and the biotech industry, the Alzheimer's Drug Discovery Foundation employs a venture philanthropy model, focusing solely on funding the development of drugs for Alzheimer's. Their team comprises 41 individuals, all committed to making a significant impact on the lives of those affected by these debilitating conditions.
Official website here: www.alzdiscovery.org
Is Alzheimer's Drug Discovery Foundation legitimate?
Alzheimer's Drug Discovery Foundation is a legitimate nonprofit organization registered as a 501(c)(3) entity. Alzheimer's Drug Discovery Foundation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $1,873,002
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,421,825
For more financial information, click here
Official website here: www.alzdiscovery.org
What is the mission statement of Alzheimer's Drug Discovery Foundation?
The Alzheimer's Drug Discovery Foundation is committed to expediting the discovery of drugs to prevent, treat, and potentially cure Alzheimer's disease and related dementias. This foundation's mission is to make a significant impact on the development of drugs for Alzheimer's, employing a venture philanthropy model to support research in both academic institutions and the biotech industry. The Alzheimer's Drug Discovery Foundation's primary focus is on accelerating the drug discovery process to combat these debilitating conditions.
Official website here: www.alzdiscovery.org
Who is the CEO of Alzheimer's Drug Discovery Foundation?
Howard Fillit Md is the Governor of Alzheimer's Drug Discovery Foundation. The CEO's salary of Alzheimer's Drug Discovery Foundation is $536,310 and their total compensation is $573,133.
Official website here: www.alzdiscovery.org
What is the revenue of Alzheimer's Drug Discovery Foundation?
Alzheimer's Drug Discovery Foundation's revenue in 2022 was $254,027,105.
Official website here: www.alzdiscovery.org
Who are the executives of Alzheimer's Drug Discovery Foundation and what are their salaries?
The average compensation at Alzheimer's Drug Discovery Foundation during 2022 was $80,362. There are 41 employees and 23 volunteers at Alzheimer's Drug Discovery Foundation.
Here are 31 key members and their salaries (Alzheimer's Drug Discovery Foundation's CEO's salary is $536,310 and their total compensation is $573,133):
- Howard Fillit Md (Founding Exec Dir And Chief Science Officer) [Trustee/Director]
- Mark Roithmayr (Ceo)
- Laura Nisenbaum (Executive Director, Drug Development)
- Karen Harris (Cfo And Head Of Mission Relate)
- Jane Mcintosh (Chief External Affairs And Philanthropy Officer)
- Sarah Giardina (Associate Director, Dxa)
- Marina D'Emic (Director Of Finance)
- Jennifer S Iselin (Director, Special Events (Outgoing))
- Alice Shure (Governor) [Trustee/Director]
- Beatriz Illescas Putzeys-Claugus (Governor) [Trustee/Director]
- Bonnie Pfeifer Evans (Governor) [Trustee/Director]
- David Weinreb (Governor) [Trustee/Director]
- Gary M Lauder (Governor) [Trustee/Director]
- Lanny Edelsohn Md (Governor) [Trustee/Director]
- Laurence Leeds Jr (Governor) [Trustee/Director]
- Leonard Lauder (Co-Chairman /Governor) [Trustee/Director]
- Melvin Goodes (Honorary Governor) [Trustee/Director]
- Miia Kivipelto Md Phd (Governor) [Trustee/Director]
- Nancy Corzine (Governor) [Trustee/Director]
- Nancy Goodes (Governor) [Trustee/Director]
- Paula Zahn (Governor) [Trustee/Director]
- Randal Sandler (Co-Vice Chairman & Secretary / Governor) [Trustee/Director]
- Richard Mohs Phd (Governor) [Trustee/Director]
- Robert Belfer (Governor) [Trustee/Director]
- Roberta Diaz Brinton Phd (Governor) [Trustee/Director]
- Ronald Lauder (Co-Chairman /Governor) [Trustee/Director]
- Sally Susman (Honorary Governor) [Trustee/Director]
- Sandra Day O'Connor (Honorary Chairman) [Trustee/Director]
- Sharon Sager (Governor) [Trustee/Director]
- Thomas Mcwilliams (Co-Vice Chairman & Treasurer / Gov.) [Trustee/Director]
- Thomas Smith Jr (Governor) [Trustee/Director]
Official website here: www.alzdiscovery.org
Where can I find the form 990 for Alzheimer's Drug Discovery Foundation?
The Alzheimer's Drug Discovery Foundation’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.alzdiscovery.org
Learn more at the official website: www.alzdiscovery.org
Mission Statement of Alzheimer's Drug Discovery Foundation
The Alzheimer's Drug Discovery Foundation (ADDF) is a leading organization relentlessly driving the discovery of novel drugs to prevent, treat, and ultimately cure Alzheimer's disease and related dementias. This nonprofit entity is committed to swiftly advancing research in academia and the biotech industry, employing a venture philanthropy approach to fund drug development efforts.
With unwavering focus, ADDF aims to bring about breakthroughs in the field, as the quest for effective treatments and a cure for Alzheimer's remains an urgent priority. By investing in cutting-edge research, the organization supports the development of promising therapeutics that hold the potential to transform the lives of those affected by these devastating conditions.
Leveraging its unique venture philanthropy model, ADDF collaborates with researchers and scientific teams to accelerate the drug discovery process, providing vital funding and resources to bring potential therapies to fruition. The foundation's mission is not simply to fund research but also to actively engage with the scientific community to ensure the most promising drug candidates progress through the development pipeline. In doing so, ADDF plays an essential role in bringing hope to millions of individuals and families impacted by Alzheimer's disease and related dementias.
Impact
This information is meant to be a general summary of Alzheimer's Drug Discovery Foundation. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Alzheimer's Drug Discovery Foundation is dedicated to rapidly accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease and related dementias. They focus solely on funding the development of drugs for Alzheimer's, utilizing a venture philanthropy model to support research in academia and the biotech industry. Through their efforts, they have significantly advanced the field of Alzheimer's drug discovery, bringing hope to millions of individuals affected by this devastating disease. Their impact is evident in the innovative research projects they fund and the promising drug candidates that have emerged as a result of their support.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
PRI INCOME
Revenue
$6,415,669
CONFERENCE REG. FEES
Revenue
$10,000
Organization Details
Founding Year
2004
Phone
(212) 901-8000
Principal Officer
Howard Fillit Md
Main Address
57 WEST 57TH ST 904, NEW YORK, NY, 10019
Website
www.alzdiscovery.org
NTEE Category
Code: F01 - Mental health
If you are a representative of Alzheimer's Drug Discovery Foundation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.